Compare Cart
Home > Publishers > La Merie Publishing
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Publisher
Filter

La Merie Publishing Report List

lmer
La Merie Business Intelligence was established in 2002 by Ulrich Martin, MD, based on his extensive experience in the biopharmaceutical industry both as a physician specializing in pharmacology and as a co-founder and CEO of a product development biotech company. The focus of our reports and subscription services such as databases and periodicals is directed towards biologs as therapeutics, such as antibodies, proteins, peptides, vaccines and biosimilars. Today we continue to publish reports, but leverage our experience, knowledge and report writing expertise to offer this service to individual customers.

Filter
Title Search
1 - 13 of 13 Products Sort by Display
Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from an Industry Perspective
Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from an Industry Perspective
Published by
La Merie Publishing
Product code
1031041
Published
October 3, 2021
Content info
433 Pages
Price
USD 2587.50
Sample available
Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis of Stakeholders, Technologies, Targets, Business and Financing From an Industry Perspective
Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis of Stakeholders, Technologies, Targets, Business and Financing From an Industry Perspective
Published by
La Merie Publishing
Product code
1017023
Published
July 1, 2021
Content info
259 Pages
Price
USD 2472.50
Sample available
Report Package - 4 for 2: "Drug the Undruggable" Technologies
Report Package - 4 for 2: "Drug the Undruggable" Technologies
Published by
La Merie Publishing
Product code
936691
Published
May 18, 2020
Content info
4 Reports
Price
USD 4743.75
Sample available
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective
Published by
La Merie Publishing
Product code
936351
Published
May 14, 2020
Content info
195 Pages
Price
USD 2357.50
Sample available
RNA-Targeted Small Molecules 2019: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective
RNA-Targeted Small Molecules 2019: A Landscape Analysis of Companies, Technologies, Targets, Investors and Partners from an Industry Perspective
Published by
La Merie Publishing
Product code
911032
Published
September 16, 2019
Content info
223 Pages
Price
USD 2357.50
Sample available
2 Reports Bundle - Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases plus T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis
2 Reports Bundle - Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases plus T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis
Published by
La Merie Publishing
Product code
890416
Published
June 30, 2019
Content info
Price
USD 2875
Sample available
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases
Published by
La Merie Publishing
Product code
890224
Published
June 30, 2019
Content info
125 Pages
Price
USD 920
Sample available
T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis
T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis
Published by
La Merie Publishing
Product code
868394
Published
June 5, 2019
Content info
463 Pages
Price
USD 2702.50
Sample available
4 Reports Bundle: Immuno-Oncology - Inhibitory and Stimulatory Immunomodulators
4 Reports Bundle: Immuno-Oncology - Inhibitory and Stimulatory Immunomodulators
Published by
La Merie Publishing
Product code
408112
Published
July 26, 2018
Content info
455 Pages
Price
USD 1656
Sample available
6 Reports Bundle: Immunotherapeutics Targeting MAGE-A, NY-ESO-1, hTERT, WT1, PRAME and Survivin
6 Reports Bundle: Immunotherapeutics Targeting MAGE-A, NY-ESO-1, hTERT, WT1, PRAME and Survivin
Published by
La Merie Publishing
Product code
651129
Published
June 12, 2018
Content info
Price
USD 931.50
Sample available
2 Reports Bundle: TCR-Based Antibody and T-Cell Immunotherapy
2 Reports Bundle: TCR-Based Antibody and T-Cell Immunotherapy
Published by
La Merie Publishing
Product code
651128
Published
May 31, 2018
Content info
Price
USD 3412.05
Sample available
TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals
TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals
Published by
La Merie Publishing
Product code
642119
Published
May 20, 2018
Content info
294 Pages
Price
USD 2472.50
Sample available
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends
Published by
La Merie Publishing
Product code
600758
Published
January 22, 2018
Content info
251 Pages
Price
USD 2645
Sample available
Compare
item is currently selected
Compare products
Delete all